Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Number of items: 38.
A
Alberro, JA;
Ballester, B;
Deulofeu, P;
Fabregas, R;
Fraile, M;
Gubern, JM;
Janer, J;
... Llombart, HA; + view all
(2018)
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.
The Lancet Oncology
, 19
(1)
pp. 27-39.
10.1016/S1470-2045(17)30777-5.
|
 |
|
Anderson, RA;
Remedios, R;
Kirkwood, AA;
Patrick, P;
Stevens, L;
Clifton-Hadley, L;
Roberts, T;
... Johnson, PWM; + view all
(2018)
Determinants of Ovarian Function After Response-adapted Therapy in Patients With Advanced Hodgkin's Lymphoma (RATHL): a Secondary Analysis of a Randomised Phase 3 Trial.
Lancet Oncology
, 19
(10)
pp. 1328-1337.
10.1016/S1470-2045(18)30500-X.
|
|
B
|
Backen, AC;
Lopes, A;
Wasan, H;
Palmer, DH;
Duggan, M;
Cunningham, D;
Anthoney, A;
... Valle, JW; + view all
(2018)
Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial.
British Journal of Cancer
, 119
pp. 27-35.
10.1038/s41416-018-0132-8.
|
|
|
Berek, JS;
Matulonis, UA;
Peen, U;
Ghatage, P;
Mahner, S;
Redondo, A;
Lesoin, A;
... Mirza, MR; + view all
(2018)
Safety and dose modification for patients receiving niraparib.
Annals of Oncology
, 29
(8)
pp. 1784-1792.
10.1093/annonc/mdy181.
|
C
|
Catto, JWF;
Khetrapal, P;
Ambler, G;
Sarpong, R;
Khan, MS;
Tan, M;
Feber, A;
... Kelly, JD; + view all
(2018)
Robot-assisted radical cystectomy with intracorporeal urinary diversion versus open radical cystectomy (iROC): protocol for a randomised controlled trial with internal feasibility study.
BMJ Open
, 8
(8)
, Article e020500. 10.1136/bmjopen-2017-020500.
|
|
|
Catto, JWF;
Khetrapal, P;
Ambler, G;
Sarpong, R;
Potyka, I;
Khan, S;
Tan, M;
... Kelly, JD; + view all
(2018)
Multidomain Quantitative Recovery Following Radical Cystectomy for Patients Within the Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion Versus Open Radical Cystectomy Randomised Controlled Trial: The First 30 Patients.
European Urology
, 74
(4)
pp. 531-534.
10.1016/j.eururo.2018.05.008.
|
|
Chapman, MA;
Sive, J;
Ambrose, J;
Roddie, C;
Counsell, N;
Lach, A;
Abbasian, M;
... Yong, K; + view all
(2018)
RNA-Seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature.
Blood
, 132
(20)
pp. 2154-2165.
10.1182/blood-2018-05-849893.
|
|
Conibear, J;
Chia, B;
Ngai, Y;
Bates, AT;
Counsell, N;
Patel, R;
Eaton, D;
... Landau, D; + view all
(2018)
Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer.
BMJ Open
, 8
(4)
, Article e020690. 10.1136/bmjopen-2017-020690.
|
|
D
|
de Boer, SM;
Powell, ME;
Mileshkin, L;
Katsaros, D;
Bessette, P;
Haie-Meder, C;
Ottevanger, PB;
... PORTEC study group, .; + view all
(2018)
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
The Lancet Oncology
, 19
(3)
pp. 295-309.
10.1016/S1470-2045(18)30079-2.
|
F
|
Farah, N;
Kirkwood, AA;
Rahman, S;
Leon, T;
Jenkinson, S;
Gale, RE;
Patrick, K;
... Mansour, MR; + view all
(2018)
Prognostic impact of the absence of biallelic deletion at theTRGlocus for pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial.
Haematologica
, 103
(7)
e288-e292.
10.3324/haematol.2017.185801.
|
|
|
Forster, M;
Hackshaw, A;
De Pas, T;
Cobo, M;
Garrido, P;
Summers, Y;
Dingemans, AMC;
... Lee, SM; + view all
(2018)
A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3).
Lung Cancer
, 120
pp. 27-33.
10.1016/j.lungcan.2018.03.007.
|
|
|
Friedlander, M;
Matulonis, U;
Gourley, C;
du Bois, A;
Vergote, I;
Rustin, G;
Scott, C;
... Ledermann, J; + view all
(2018)
Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy.
British Journal of Cancer
, 119
pp. 1075-1085.
10.1038/s41416-018-0271-y.
|
|
G
|
Glynne-Jones, R;
Hall, MR;
Lopes, A;
Pearce, S;
Goh, V;
Bosompem, S;
Bridgewater, J;
... Harrison, M; + view all
(2018)
BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC).
Heliyon
, 4
(9)
, Article e00804. 10.1016/j.heliyon.2018.e00804.
|
|
|
Gohil, SH;
Maciocia, N;
Patrick, P;
Roberts, T;
Counsell, N;
Smith, P;
Clifton-Hadley, L;
... Nathwani, AC; + view all
(2018)
LenD: a study to establish the safety and efficacy of lenalidomide and dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia.
Leukemia & Lymphoma
, 59
(7)
pp. 1730-1733.
10.1080/10428194.2017.1399311.
|
H
|
Hackshaw, AK;
Morris, JK;
Boniface, S;
Tang, JL;
Milenkovic, D;
(2018)
Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports.
BMJ
, 2018
(360)
, Article j3984. 10.1136/bmj.j5855.
|
|
|
Hainsworth, EG;
Shahmanesh, M;
Stevenson, F;
(2018)
Exploring the views and experiences of HIV positive patients treated for cancer: a systematic review of the literature.
AIDS Care
, 30
(5)
pp. 535-543.
10.1080/09540121.2017.1381332.
|
|
Hodgson, DR;
Dougherty, BA;
Lai, Z;
Fielding, A;
Grinsted, L;
Spencer, S;
O'Connor, MJ;
... Barrett, JC; + view all
(2018)
Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes.
British Journal of Cancer
, 119
pp. 1401-1409.
10.1038/s41416-018-0274-8.
|
|
Hynds, RE;
Ben Aissa, A;
Gowers, KHC;
Watkins, TBK;
Bosshard-Carter, L;
Rowan, AJ;
Veeriah, S;
... Janes, SM; + view all
(2018)
Expansion of airway basal epithelial cells from primary human non-small cell lung cancer tumors.
International Journal of Cancer
, 143
(1)
pp. 160-166.
10.1002/ijc.31383.
|
|
K
|
Kerrison, R;
McGregor, LM;
Von Wagner, C;
Counsell, N;
(2018)
Use of two self-referral reminders and a theory-based leaflet to increase the uptake of flexible sigmoidoscopy in the English Bowel Scope Screening Programme: results from a randomised controlled trial in London.
Annals of Behavioral Medicine
, 52
(11)
pp. 941-951.
10.1093/abm/kax068.
|
|
L
|
Langley, RE;
Duong, T;
Clarke, NW;
Kynaston, K;
Rosen, SD;
Nankivell, M;
Dearnaley, D;
... Abel, P; + view all
(2018)
PATCH - Prostate adenocarcinoma: transcutaneous hormones. A randomised comparison evaluating cardiovascular morbidity and mortality of transdermal oestradiol versus luteinising hormone-releasing hormone agonists in advanced prostate cancer.
Presented at: The British Associations of Urological Surgeons (BAUS) Annual Scientific Meeting, Liverpool, UK.
|
|
|
Ledermann, JA;
(2018)
First-line treatment of ovarian cancer: questions and controversies to address.
Therapeutic Advances in Medical Oncology
, 10
pp. 1-8.
10.1177/1758835918768232.
|
M
|
Mirza, MR;
Pignata, S;
Ledermann, JA;
(2018)
Latest clinical evidence and further development of PARP inhibitors in ovarian cancer.
Annals of Oncology
, 29
(6)
pp. 1366-1376.
10.1093/annonc/mdy174.
|
P
|
Pallmann, P;
Sydes, MR;
Other authors, M;
(2018)
Adaptive designs in clinical trials: why use them, and how to run and report them.
BMC Medicine
, 16
, Article 29. 10.1186/s12916-018-1017-7.
|
|
Pilotti, Camilla;
(2018)
Complement Factor B and pathological angiogenesis in age-related macular degeneration.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Provencher, DM;
Gallagher, CJ;
Parulekar, WR;
Ledermann, JA;
Armstrong, DK;
Brundage, M;
Gourley, C;
... MacKay, HJ; + view all
(2018)
OV21/PETROC: a randomized Gynecologic Cancer Intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer.
Annals of Oncology
, 29
(2)
pp. 431-438.
10.1093/annonc/mdx754.
|
R
|
Roncalato, FT;
Berton-Rigaud, D;
O'Connell, R;
Lanceley, A;
Sehouli, J;
Buizen, L;
Okamoto, A;
... Friedlander, M; + view all
(2018)
Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) – Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS).
Gynecologic Oncology
, 148
(1)
pp. 36-41.
10.1016/j.ygyno.2017.10.019.
|
T
|
Tan, WS;
Feber, A;
Sarpong, R;
Khetrapal, P;
Rodney, S;
Jalil, R;
Mostafid, H;
... Kelly, JD; + view all
(2018)
Who Should Be Investigated for Haematuria? Results of a Contemporary Prospective Observational Study of 3556 Patients.
European Urology
, 74
(1)
pp. 10-14.
10.1016/j.eururo.2018.03.008.
|
|
Tan, WS;
Sarpong, R;
Khetrapal, P;
Rodney, S;
Mostafid, H;
Cresswell, J;
Hicks, J;
... DETECT I trial collaborators; + view all
(2018)
Can renal and bladder ultrasound replace CT urogram in patients investigated for microscopic hematuria?
The Journal of Urology
, 200
(5)
10.1016/j.juro.2018.04.065.
|
|
|
Tan, WS;
Sarpong, R;
Khetrapal, P;
Rodney, S;
Mostafid, H;
Cresswell, J;
Watson, D;
... DETECT I trial collaborators, .; + view all
(2018)
Does urinary cytology have a role in haematuria investigations?
BJU International
10.1111/bju.14459.
|
|
V
|
Vargas, FA;
Furness, AJS;
Litchfield, K;
Joshi, K;
Rosenthal, R;
Ghorani, E;
Solomon, I;
... Quezada, SA; + view all
(2018)
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies.
Cancer Cell
, 33
(4)
pp. 649-663.
10.1016/j.ccell.2018.02.010.
|
|
|
Veiga, C;
Landau, D;
Devaraj, A;
Doel, T;
White, J;
Ngai, Y;
Hawkes, D;
(2018)
Novel CT-based objective imaging biomarkers of long term radiation-induced lung damage.
International Journal of Radiation Oncology - Biology - Physics
, 102
(4)
10.1016/j.ijrobp.2018.06.006.
|
|
Veiga, C;
Landau, D;
McClelland, JR;
Ledermann, JA;
Hawkes, D;
Janes, SM;
Devaraj, A;
(2018)
Long term radiological features of radiation-induced lung damage.
Radiotherapy and Oncology
, 126
(2)
pp. 300-306.
10.1016/j.radonc.2017.11.003.
|
|
Vergote, I;
Coens, C;
Nankivell, M;
Kristensen, GB;
Parmar, MKB;
Ehlen, T;
Jayson, GC;
... MRC CHORUS study investigators, .; + view all
(2018)
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials.
Lancet Oncology
, 19
(12)
pp. 1680-1687.
10.1016/S1470-2045(18)30566-7.
|
|
Vesely, C;
Childs, A;
Wong, YNS;
Ogunbiyi, O;
Gander, A;
Luong, T;
Thirlwell, C;
... Meyer, T; + view all
(2018)
Systematic Evaluation of the Immune Microenvironment of Neuroendocrine Tumors (NET).
Presented at: 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain.
|
W
|
Walf-Vorderwülbecke, V;
Pearce, K;
Brooks, T;
Hubank, M;
Van den Heuvel-Eibrink, MM;
Zwaan, CM;
Adams, S;
... Williams, O; + view all
(2018)
Targeting acute myeloid leukemia by drug-induced c-MYB degradation.
Leukemia
, 32
pp. 882-889.
10.1038/leu.2017.317.
|
|
Wheeler, GM;
Mander, A;
Yap, C;
(2018)
Practical implementation of dose-response adaptive trials.
In:
Wiley Statsref: Statistics Reference Online.
Wiley: Hoboken, NJ, USA.
|
|
Whelan, J;
Hackshaw, A;
McTiernan, A;
Grimer, R;
Spooner, D;
Bate, J;
Ranft, A;
... Lewis, I; + view all
(2018)
Survival is influenced by approaches to local treatment of Ewing sarcoma within an international randomised controlled trial: analysis of EICESS-92.
Clinical Sarcoma Research
, 8
, Article 6. 10.1186/s13569-018-0093-y.
|
|
|
Wong, YNS;
Joshi, K;
Khetrapal, P;
Ismail, M;
Reading, JL;
Sunderland, MW;
Georgiou, A;
... Quezada, SA; + view all
(2018)
Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironment.
Journal of Experimental Medicine
, 215
(11)
pp. 2748-2759.
10.1084/jem.20181003.
|
|
